Ultraviolet Light Therapy Using Methoxsalen With or Without Bexarotene in Treating Patients With Mycosis Fungoides
Status:
Terminated
Trial end date:
2011-06-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Ultraviolet light therapy uses light and drugs that make cancer cells more
sensitive to light to kill tumor cells. It is not yet known whether ultraviolet light therapy
is more effective with or without bexarotene in treating mycosis fungoides.
PURPOSE: Randomized phase III trial to compare the effectiveness of ultraviolet light therapy
using methoxsalen with or without bexarotene in treating patients who have mycosis fungoides.
Phase:
Phase 3
Details
Lead Sponsor:
European Organisation for Research and Treatment of Cancer - EORTC